We further established the NEAT1 knockdown and NEAT1 overexpression A549/PTX cells to explore the role of NEAT1/Akt signaling in shikonin against paclitaxel-resistant NSCLC (Fig. 4). Here, AKT1 is linked to non-small cell lung carcinoma.